Open Access

[Corrigendum] MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer

  • Authors:
    • Shengjie Wang
    • Mingliang Huang
    • Zichen Wang
    • Wan Wang
    • Zhiyuan Zhang
    • Shuting Qu
    • Chun Liu
  • View Affiliations

  • Published online on: June 6, 2023     https://doi.org/10.3892/ijo.2023.5531
  • Article Number: 83
  • Copyright : © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

July-2023
Volume 63 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang S, Huang M, Wang Z, Wang W, Zhang Z, Qu S and Liu C: [Corrigendum] MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer. Int J Oncol 63: 83, 2023
APA
Wang, S., Huang, M., Wang, Z., Wang, W., Zhang, Z., Qu, S., & Liu, C. (2023). [Corrigendum] MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer. International Journal of Oncology, 63, 83. https://doi.org/10.3892/ijo.2023.5531
MLA
Wang, S., Huang, M., Wang, Z., Wang, W., Zhang, Z., Qu, S., Liu, C."[Corrigendum] MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer". International Journal of Oncology 63.1 (2023): 83.
Chicago
Wang, S., Huang, M., Wang, Z., Wang, W., Zhang, Z., Qu, S., Liu, C."[Corrigendum] MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer". International Journal of Oncology 63, no. 1 (2023): 83. https://doi.org/10.3892/ijo.2023.5531